Webcast - Replay Array BioPharma Inc. at UBS Global Healthcare Conference 05/21/13 at 8:30 a.m. ET

Receive E-mail Alerts

RSS Feeds

Keyword Search

2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006

05/15/13 Array BioPharma Announces Clinical Data Presentations At The 2013 ASCO Annual Meeting 05/08/13 Array BioPharma to Present at the Bank of America Merrill Lynch Healthcare Conference and the UBS Global Healthcare Conference 05/06/13 Array BioPharma Reports Financial Results for the Third Quarter of Fiscal 2013 05/06/13 Array Announces Global Phase 3 Trial Evaluating MEK162 In Patients With Low-Grade Serous Ovarian Cancer 04/29/13 Array BioPharma To Report Financial Results For The Third Quarter Of Fiscal 2013 On May 6, 2013 04/04/13 Array BioPharma Announces Updates on ARRY-520 Clinical Data at the 2013 International Myeloma Workshop 03/21/13 Array BioPharma Names Michael N. Needle, M.D. As Chief Medical Officer 03/05/13 Array Biopharma and Global Blood Therapeutics Announce Drug Discovery Collaboration Focused on Hematology 02/26/13 Array BioPharma To Present At The Cowen Annual Health Care Conference 02/08/13 Array BioPharma To Present At The Leerink Swann Global Healthcare Conference 02/04/13 Array BioPharma Reports Financial Results For The Second Quarter Of Fiscal 2013 01/29/13 Array BioPharma To Report Financial Results For The Second Quarter Of Fiscal 2013 On February 4, 2013 12/27/12 Array BioPharma To Present At The Annual J.P. Morgan Healthcare Conference 12/10/12 Array BioPharma Provides Updates On Clinical Data At The 2012 American Society Of Hematology Meeting 12/05/12 Array BioPharma Announces Exercise And Closing Of Underwriters' Over-Allotment Option 11/15/12 Array BioPharma To Present At The Piper Jaffray Annual Healthcare Conference 11/09/12 Array BioPharma Announces Pricing Of Public Offering Of Common Stock 11/08/12 Array BioPharma Announces Proposed Public Offering Of Common Stock 11/08/12 MEK162 Registration Path Announced 11/07/12 John A. Orwin Joins Array BioPharma Board Of Directors 11/07/12 Array BioPharma to Present at the Lazard Annual Healthcare and Jefferies 2012 Global Healthcare Conferences 11/06/12 Array BioPharma To Present Clinical Data On ARRY-797 At The 2012 American College Of Rheumatology Annual Meeting 11/05/12 Array BioPharma To Present Clinical Data At The 2012 ASH Meeting On ARRY-520, A KSP Inhibitor, And ARRY-614, A Dual p38/Tie2 Inhibitor 11/01/12 Array BioPharma to Hold Conference Call on Monday, November 5, 2012 to Discuss Submitted ASH Abstracts 10/29/12 Array BioPharma Reports Financial Results For The First Quarter Of Fiscal 2013 10/23/12 Array BioPharma To Report Financial Results For The First Quarter Of Fiscal 2013 On October 29, 2012 09/11/12 Array BioPharma to Present at the UBS Global Life Sciences Conference 08/31/12 Array BioPharma Announces Changes to Board of Directors 08/29/12 Array BioPharma to Present at the Stifel Nicolaus Healthcare, NewsMakers in the Biotech Industry and Morgan Stanley Global Healthcare Conferences 08/13/12 Array BioPharma Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2012 08/06/12 Array BioPharma to Report Financial Results for the Fourth Quarter and Full Year of Fiscal 2012 on August 13, 2012 07/31/12 Array BioPharma’s ARRY-797 Meets Primary Endpoint in Clinical Proof of Concept Trial in Osteoarthritis Patients Whose Pain is Poorly Controlled by NSAIDs 07/24/12 Array BioPharma Names Andrew Robbins as Senior Vice President, Commercial Operations 07/19/12 Array BioPharma Achieves $8.5 Million Clinical Milestone in Amgen Diabetes Collaboration 07/16/12 Clovis Oncology and Array BioPharma Announce Agreement to Discover Novel Mutant KIT Inhibitor 07/03/12 Array BioPharma to Present at the JMP Securities Healthcare Conference 2012 06/04/12 Promising Data for KRAS Mutant Advanced NSCLC Patients Presented at ASCO 06/04/12 MEK162 Shows Promising Clinical Activity in Ongoing Phase 2 Trial 05/30/12 Array BioPharma to Present at the Jefferies 2012 Global Healthcare Conference 05/16/12 Array BioPharma Announces Clinical Data Presentations at the 2012 ASCO Annual Meeting 05/14/12 Array BioPharma and Genentech's Strategic Alliance Voted Breakthrough Alliance of 2012 04/30/12 Array BioPharma Names Liam Ratcliffe, M.D., Ph.D., to Board of Directors 04/30/12 Array BioPharma Reports Financial Results for the Third Quarter of Fiscal 2012 04/26/12 Array BioPharma Names Ron Squarer Chief Executive Officer 04/23/12 Array BioPharma to Report Financial Results for the Third Quarter of Fiscal 2012 on April 30, 2012 04/16/12 Array BioPharma Names Howard Holden, Ph.D., Vice President of Regulatory Affairs and Quality Assurance 04/04/12 Encouraging Selumetinib Results Announced for Phase 2 Trial in Ovarian Cancer 03/31/12 Selumetinib Controlled Recurrent Low-grade Serous Ovarian Cancer 02/27/12 Array BioPharma to Present at the Cowen and Company 32nd Annual Health Care Conference 02/14/12 Array BioPharma Announces Closing of Public Offering of Common Stock and Exercise of Overallotment Option 02/09/12 Array BioPharma to Present at the Leerink Swann Global Healthcare Conference 02/08/12 Array BioPharma Announces Proposed Public Offering of Common Stock 01/30/12 Array BioPharma Names Gwen A. Fyfe, M.D. to Board of Directors 01/30/12 Array BioPharma Reports Financial Results for the Second Quarter of Fiscal 2012 01/23/12 Array BioPharma to Report Financial Results for the Second Quarter of Fiscal 2012 on January 30, 2012 01/16/12 Array BioPharma's Chief Executive Officer Robert E. Conway Resigns 01/04/12 Array BioPharma to Present at the 30th Annual J.P. Morgan Healthcare Conference 12/11/11 ARRY-614 Demonstrates Positive Single Agent Activity in Patients with Myelodysplastic Syndromes 12/11/11 ARRY-520 Demonstrates Durable Single-Agent Activity in Patients with Advanced Multiple Myeloma 12/01/11 Array BioPharma to Host Analyst and Investor Day Featuring Distinguished Clinical Investigators 11/29/11 Array Biopharma to Present Clinical Data on ARRY-520, a KSP Inhibitor, and ARRY-614, a Dual p38/Tie2 Inhibitor, at the 2011 American Society of Hematology Annual Meeting 11/17/11 Array BioPharma to Present at the Piper Jaffray Health Care Conference 10/31/11 Array BioPharma Reports Financial Results for the First Quarter of Fiscal 2012 10/24/11 Array BioPharma to Report Financial Results for the First Quarter of Fiscal 2012 on October 31, 2011 09/30/11 Topline Results:A Randomized Phase 2 Study of Selumetinib in Patients with KRAS-Mutant Non-Small Cell Lung Cancer 09/13/11 Array BioPharma to Present at the UBS Global Life Sciences Conference 09/08/11 Array BioPharma Names Karsten Witt, M.D., Vice President of Clinical Sciences 08/29/11 Array BioPharma to Present at the Stifel Nicolaus Healthcare Conference and the Rodman & Renshaw Global Investment Conference 08/08/11 Array BioPharma Reports Results for the Fourth Quarter and Full Year of Fiscal 2011 08/08/11 Array Announces New Oncology Agreement with Genentech 08/04/11 Array BioPharma to Report Financial Results for the Fourth Quarter and Full Year of Fiscal 2011 on August 8, 2011 07/13/11 Array BioPharma Licenses Cancer Drug ARRY-543 to ASLAN Pharmaceuticals 06/13/11 Array BioPharma Announces Restructuring 05/31/11 Array BioPharma to Present at the Jefferies 2011 Global HealthcareConference 05/02/11 Array BioPharma Announces $30 Million Debt Reduction and a Loan Term Extension to 2015 and 2016 05/02/11 Array BioPharma Reports Financial Results for the Third Quarter of Fiscal 2011 04/25/11 Array BioPharma to Report Financial Results for the Third Quarter of Fiscal 2011 on May 2, 2011 04/07/11 Array BioPharma Achieves $10 Million Clinical Milestone in MEK162 Oncology Program 04/01/11 Array BioPharma Announces Five Abstracts Selected for Presentation at 2011 AACR Annual Meeting 03/29/11 Array BioPharma to Present at the Leerink Swann Cancer RoundtableConference 03/08/11 Array BioPharma to Present at the Roth 23rd Annual OC Growth Stock Conference and the Barclay's Capital 2011 Global Healthcare Conference 02/28/11 Array BioPharma to Present at the Cowen and Company 31st Annual Health Care Conference 01/31/11 Array BioPharma Reports Financial Results for the Second Quarter of Fiscal 2011 01/24/11 Array BioPharma to Report Financial Results for the Second Quarter of Fiscal 2011 on January 31, 2011 01/04/11 Array BioPharma to Present at the 29th Annual J.P. Morgan Healthcare Conference 12/04/10 Array BioPharma's Arry-520 Demonstrates Single Agent Activity in Advanced Multiple Myeloma Patients 11/30/10 Array BioPharma Achieves Clinical Milestone in Celgene Collaboration 11/29/10 Array BioPharma to Present ARRY-520 / KSP Inhibitor Data at2010 ASH Annual Meeting 11/16/10 Array BioPharma to Present at the 22nd Annual Piper Jaffray Health Care Conference 11/11/10 Array BioPharma to Present at the Lazard Capital Markets 7th Annual Healthcare Conference 11/08/10 Array BioPharma Reports Financial Results for the First Quarter of Fiscal 2011 11/02/10 Array BioPharma to Report Financial Results for the First Quarter of Fiscal 2011 on November 8, 2010 10/01/10 Array BioPharma Announces Positive Results for HER2 Inhibitor, ARRY-380, in Breast Cancer Patients 09/13/10 Array BioPharma to Present at the UBS Global Life Sciences Conference 09/07/10 Array BioPharma to Present at the Rodman & Renshaw Global Investment Conference and the Stifel Nicolaus Healthcare Conference 08/09/10 Array BioPharma Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2010 08/03/10 Array BioPharma to Report Financial Results for the Fourth Quarter and Full Year of Fiscal 2010 on August 9, 2010 06/05/10 Array BioPharma's ARRY-520Well Tolerated and Demonstrates Preliminary Activity as a Single Agent in Multiple Myeloma Patients 06/01/10 Array BioPharma to Present at the Jefferies 2010 Global Life Sciences Conference 05/20/10 Array BioPharma Announces Abstracts Selected for Presentation at 2010 ASCO Annual Meeting 05/03/10 Array BioPharma Reports Financial Results for the Third Quarter of Fiscal 2010 04/26/10 Array BioPharma to Report Financial Results for the Third Quarter of Fiscal 2010 on May 3, 2010 04/19/10 Array BioPharma Signs Strategic Oncology Collaboration 04/12/10 Array BioPharma Announces Eight Abstracts Selected for Presentation at 2010 AACR Annual Meeting 02/01/10 Array BioPharma Reports Financial Results for the Second Quarter of Fiscal 2010 02/01/10 Array BioPharma to Present at the 12th Annual BIO CEO & Investor Conference 01/26/10 Array BioPharma Names Bengt Bergstrom, M.D., Ph.D., Vice President, Clinical Development 01/25/10 Array BioPharma to Report Financial Results for the Second Quarter of Fiscal 2010 on February 1, 2010 01/04/10 Array BioPharma to Present at the JP Morgan 28th Annual Healthcare Conference 12/14/09 Array BioPharma and Amgen Partner in Type 2 Diabetes 12/12/09 Array BioPharma Announces Positive Interim Results for Phase 1 Study of Its HER2 Inhibitor, ARRY-380, in Cancer Patients 11/23/09 Array BioPharma to Present at the Piper Jaffray Healthcare Conference 11/02/09 Array BioPharma Reports Financial Results for the First Quarter of Fiscal 2010 10/28/09 Array BioPharma to Report Financial Results for the First Quarter of Fiscal 2010 on November 2, 2009 10/01/09 Array BioPharma to Present Clinical Results on Diabetes Drug at European Diabetes Meeting 09/18/09 Array BioPharma Enters into Equity Distribution Agreement 09/15/09 Array BioPharma to Present at the UBS Global Life Sciences Conference 09/03/09 Array BioPharma Announces Top-Line Results from Rheumatoid Arthritis Phase 2 Trial 09/02/09 Array BioPharma to Present at the Baird 2009 Healthcare Conference and the Thomas Weisel Partners 2009 Healthcare Conference 08/10/09 Array BioPharma Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2009 08/10/09 Array BioPharma Reports Positive Results of Its Oral Glucokinase Activator in Type 2 Diabetes Patients 08/05/09 Array BioPharma to Report Financial Results for the Fourth Quarter and Full Year of Fiscal 2009 on August 10, 2009 07/15/09 Array BioPharma Advances Its Lead MEK Inhibitor into Cancer 07/08/09 Array BioPharma Announces Top-Line Results in Two Phase 1 Clinical Trials 06/11/09 Array BioPharma to Present at the Jefferies 3rd Annual Healthcare Conference 06/02/09 Array BioPharma Recognized by CIO Magazine as One of the CIO 100 Award Honorees 05/19/09 Array BioPharma Receives Additional $40 Million Funding Commitment 05/12/09 Array BioPharma to Present at Leerink Swann Oncology Roundtable Conference 05/04/09 Array BioPharma Reports Financial Results for the Third Quarter of Fiscal 2009 04/29/09 Array BioPharma to Report Financial Results for the Third Quarter of Fiscal 2009 on May 4, 2009 04/21/09 Array BioPharma's ARRY-520 Demonstrates Significant Activity in Hematological and Taxane-Resistant Tumors 04/21/09 Array BioPharma Presents Initial Data on Novel Class of Chk1 Inhibitors 04/21/09 Array BioPharma's ARRY-543 Shows Potential Clinical Benefit in Cancer Patients 04/19/09 Array BioPharma's ARRY-614 Demonstrates Cytokine Inhibition and Anti-Tumor Activity in Preclinical Models of Hematological Cancers 04/08/09 Array BioPharma Initiates Clinical Trial in Type 2 Diabetic Patients 04/06/09 Array BioPharma Announces Eighteen Abstracts Selected for Presentation at 2009 AACR Annual Meeting 03/03/09 Array BioPharma to Present at the Barclays Capital Global HealthCare Conference 02/02/09 Array BioPharma Reports Financial Results for the Second Quarter of Fiscal 2009 02/02/09 Array BioPharma to Present at the BIO CEO & Investor Conference 01/26/09 Array BioPharma to Report Financial Results for the Second Quarter of Fiscal 2009 on February 2, 2009 01/09/09 Array BioPharma Accelerates Partnering Activities and Scales Back Discovery Research to Extend Available Capital 01/09/09 Array BioPharma Initiates Phase 1 Clinical Trial for MEK Inhibitor ARRY-300 12/23/08 Array BioPharma Receives $40 Million from Deerfield 12/16/08 Array BioPharma to Present at the JP Morgan 27th Annual Healthcare Conference 11/20/08 Array BioPharma to Present at the Piper Jaffray Health Care Conference 11/07/08 Array BioPharma Inc. Files Shelf Registration Statement 11/03/08 Array BioPharma Reports Financial Results for the First Quarter of Fiscal 2009 10/27/08 Array BioPharma to Report Financial Results for the First Quarter of Fiscal 2009 on November 3, 2008 10/26/08 Array BioPharma's Oral p38 Inhibitor Demonstrates Significant Analgesic Benefit and Systemic Anti-Inflammatory Activity 10/20/08 Array BioPharma to Present Clinical Data at the 2008 ACR/ARHP Annual Scientific Meeting 09/29/08 Array BioPharma to Present at the William Blair Small-Cap Growth Stock Conference 09/25/08 Array BioPharma Presents Positive Preclinical Data on Its Glucokinase Activators in Type 2 Diabetes 09/16/08 Array BioPharma to Present at the UBS Global Life Sciences Conference 09/02/08 Array BioPharma to Present at the Morgan Stanley Global Healthcare Unplugged Conference and the Baird Small Cap Healthcare Conference 08/27/08 Array BioPharma to Present at the Thomas Weisel Partners 2008 Healthcare Conference 08/11/08 Array BioPharma Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2008 07/30/08 Array BioPharma to Present at the Bank of America 2008 Specialty Pharmaceuticals Conference 07/28/08 Array BioPharma to Report Financial Results for the Fourth Quarter and Full Year of Fiscal 2008 on August 11, 2008 06/30/08 Array BioPharma to Present at the Collins Stewart 4th Annual Growth Conference 06/16/08 Array BioPharma to Present at the Jefferies 2nd Annual Healthcare Conference 06/12/08 Array BioPharma Presents Additional Positive Phase 1 Results in Two Programs at the 2008 Annual European Congress of Rheumatology 06/10/08 Array BioPharma to Present Clinical Data at the 2008 Annual European Congress of Rheumatology 06/09/08 Array BioPharma to Present at the Jefferies 2nd Annual Healthcare Conference 05/16/08 Array BioPharma to Present at the Citi 2008 Global Healthcare Conference 05/15/08 Array BioPharma and AstraZeneca Announce New Phase 2 Development Plans for the Investigational Anti-Cancer Drug AZD6244 (ARRY-886) 05/08/08 Array BioPharma to Present at the Bank of America Securities Healthcare Conference 05/07/08 Array BioPharma Presents Additional Positive Phase 2 Results in Inflammatory Pain Clinical Trial at the American Pain Society's Annual Scientific Meeting 05/05/08 Array BioPharma Reports Financial Results for the Third Quarter of Fiscal 2008 05/05/08 Array BioPharma Receives $80 Million Funding Commitment 05/05/08 Array BioPharma to Present at Leerink Swann Conference 04/30/08 Array BioPharma to Report Financial Results for the Third Quarter of Fiscal 2008 on May 5, 2008 03/25/08 Array BioPharma Advances p38 / Tie2 Inhibitor, ARRY-614, into Phase 1 Clinical Trial 03/18/08 Array BioPharma Names Gary M. Clark, Ph.D., Vice President, Biostatistics and Data Management 03/13/08 Array BioPharma to Present at the Lehman Brothers Global Healthcare Conference 03/03/08 Array BioPharma Announces Positive Phase 2 Top-Line Results in Inflammatory Pain Clinical Trial 03/03/08 Array BioPharma to Present at the Susquehanna Healthcare Conference 02/06/08 Array BioPharma to Present at the 2008 BIO CEO & Investor Conference 02/04/08 Array BioPharma Reports Financial Results for the Second Quarter of Fiscal 2008 01/31/08 Array BioPharma to Report Financial Results for the Second Quarter of Fiscal 2008 on February 4, 2008 01/03/08 Array BioPharma to Present at the 26th Annual JPMorgan Healthcare Conference 12/19/07 Topline Results Announced from a Phase 2 Study in Advanced Melonoma of Investigational Anti-Cancer Drug AZD6244 (ARRY-886) 11/20/07 Array BioPharma Advances p38 Inhibitor, ARRY-797, into Phase 2 Clinical Trial 11/20/07 Array BioPharma to Present at the 19th Annual Piper Jaffray Health Care Conference 11/05/07 Array BioPharma Reports Financial Results for the First Quarter of Fiscal 2008 10/31/07 Array BioPharma to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference 10/31/07 Array BioPharma to Report Financial Results for the First Quarter of Fiscal 2008 on November 5, 2007 10/24/07 Array BioPharma Reports Positive New Data on ErbB-2 / EGFR Inhibitor, ARRY-543 10/22/07 Array BioPharma to Present Clinical Data at the 2007 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 09/24/07 Array BioPharma and Celgene Corporation Announce Strategic Global R&D Collaboration 09/17/07 Array BioPharma to Present at the UBS Global Life Sciences Conference 08/29/07 Array BioPharma to Present at the Thomas Weisel Partners Healthcare Conference 08/06/07 Array BioPharma Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2007 08/03/07 Array BioPharma Advances ErbB-2 Inhibitor, ARRY-380, into Phase 1 Cancer Patient Trial 08/02/07 Array BioPharma to Report Financial Results for the Fourth Quarter and Full Year of Fiscal 2007 on August 6, 2007 07/05/07 Array BioPharma to Present at the C.E Unterbeg, Towbin Emerging Growth Conference 06/21/07 Array BioPharma to Present at the Jefferies Healthcare Conference 06/20/07 Array BioPharma Reports New Clinical Data on Its Anti-Inflammatory Drugs 06/06/07 Array BioPharma to Present at the Needham Biotechnology & Medical Technology Conference 05/30/07 Array BioPharma to Present Clinical Data at the European League Against Rheumatism (EULAR) Annual Meeting and the 8th World Congress on Inflammation 05/23/07 Array BioPharma to Present at the Banc of America Securities Healthcare Conference 05/15/07 Array BioPharma Appoints John Yates, MB ChB, MD, to Chief Medical Officer 05/08/07 Array BioPharma Appoints Dr. Jonathan Kay to Its Scientific Advisory Board for Inflammation Therapy 05/03/07 Array BioPharma Initiates Phase 1 Clinical Trial for Anticancer KSP Inhibitor ARRY-520 05/01/07 Array BioPharma Inc. Announces Pricing of Proposed Public Offering of Common Stock 04/23/07 Array BioPharma Reports Financial Results for the Third Quarter of Fiscal 2007 04/23/07 Array BioPharma Inc. Announces Proposed Public Offering of Common Stock 04/18/07 Array BioPharma Appoints Dr. Neil Spector to Its Scientific Advisory Board 04/12/07 Array BioPharma Achieves Milestone for Dosing MEK Inhibitor, ARRY-704, in Phase 1 Clinical Trial 04/10/07 Array BioPharma Advances p38 Inhibitor, ARRY-797, into Phase 1 Cancer Patient Trial 03/14/07 Array BioPharma to Present at the Lehman Brothers Annual Global Healthcare Conference 03/13/07 Array BioPharma and VentiRx Pharmaceuticals Announce License Agreement 02/06/07 Array BioPharma to Present at the BIO CEO & Investor Conference 02/05/07 Array BioPharma Reports Financial Results for the Second Quarter of Fiscal 2007 01/30/07 Array BioPharma to Report Financial Results for the Second Quarter of Fiscal 2007 on February 5, 2007 12/28/06 Array BioPharma's KSP Inhibitor for Cancer to Advance into Human Clinical Trials 12/22/06 Array BioPharma to Present at the 25th Annual JPMorgan Healthcare Conference 11/28/06 Array BioPharma Announces Analyst Event and Live Webcast in New York City 11/21/06 Array BioPharma to Present at the Piper Jaffray Health Care Conference 11/08/06 Enzyme inhibitor produces stable disease in patients with advanced solid cell cancers: phase II trials initiated 11/06/06 Array BioPharma Reports Financial Results for the First Quarter of Fiscal 2007 11/06/06 Array BioPharma Announces Clinical Trial Data With AZD6244 (ARRY-142886) To Be Presented at the 2006 EORTC-NCI-AACR International Meeting 10/31/06 Array BioPharma's p38 Inhibitor for Inflammatory Disease to Advance into Human Clinical Trials 10/31/06 Array BioPharma to Report Financial Results for the First Quarter of Fiscal 2007 on November 6, 2006 10/23/06 Array BioPharma to Present at the C.E. Unterberg, Towbin Life Sciences Conference 10/19/06 Array BioPharma Reports MEK Inhibitor, ARRY-438162, Meets Initial Clinical Objectives 10/06/06 Array BioPharma Inc. Files Shelf Registration Statement 10/03/06 Array BioPharma to Present Inflammation Pipeline at the 14th International IRA Conference 09/14/06 Array BioPharma Receives Phase 2 Milestone Payment From AstraZeneca 09/14/06 Array BioPharma to Present at the UBS Global Life Sciences Conference 09/14/06 Array BioPharma to Present at the Leerink Swann & Company Cancer Medicines on the Horizon Conference 08/28/06 Array BioPharma to Present at the Thomas Weisel Partners Healthcare Conference 08/28/06 Array BioPharma to Present at the Roth Capital Partners 2006 New York Conference 08/10/06 Array BioPharma Receives $14 Million From Longmont Facilities Transaction 08/07/06 Array BioPharma Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2006 08/01/06 Array BioPharma to Present at the 26th Annual Canaccord Adams Summer Seminar 07/31/06 Array BioPharma to Report Financial Results for the Fourth Quarter and Full Year of Fiscal 2006 on August 7, 2006 07/11/06 Array BioPharma Receives $18 Million From Boulder Facilities Transaction 07/06/06 Array BioPharma to Present at the C.E. Unterberg, Towbin Emerging Growth Conference 06/22/06 Array BioPharma to Obtain $32 Million in Additional Cash From Facilities Transactions 06/20/06 Array BioPharma to Present at the Jefferies Life Sciences Conference 06/08/06 AstraZeneca and Array BioPharma Announce Initiation of Phase II Studies for AZD6244 (ARRY-142886) 06/05/06 Array BioPharma to Present at the Needham Annual Biotechnology & Medical Technology Conference 05/01/06 Array BioPharma Reports Financial Results for the Third Quarter of Fiscal 2006 04/26/06 Array BioPharma Initiates Phase 1 Clinical Trial of Its MEK Inhibitor for Inflammatory Disease 04/25/06 Array Biopharma to Report Financial Results for the Third Quarter of Fiscal 2006 on May 1, 2006 04/17/06 Array BioPharma Achieves Research Milestone in Genentech Collaboration 04/10/06 Array BioPharma Achieves Milestone for Selection of Third Compound for MEK Anti-Cancer Program 03/14/06 Array BioPharma Announces KSP Anti-Cancer Program 02/08/06 Array BioPharma to Present at the Roth Capital Partners Annual Growth Stock Conference 02/06/06 Array BioPharma Reports Financial Results for the Second Quarter of Fiscal 2006 02/01/06 Array BioPharma to Present at the BIO CEO & Investor Conference 2006 01/30/06 Array BioPharma to Report Financial Results for the Second Quarter of Fiscal 2006 on February 6, 2006 01/24/06 Array BioPharma Achieves Milestone for Selection of Second Clinical Candidate for MEK Anti-Cancer Program 01/17/06 Array BioPharma Initiates Phase I Clinical Trial for Targeted Anticancer Drug ARRY-334543 12/13/05 Co-Founder of Array BioPharma to Lead New Korean Out-Sourcing Chemistry Company 11/08/05 Array BioPharma to Present Phase IA Data From Anti-Cancer Compound at the AACR-NCI-EORTC International Conference On Molecular Targets And Cancer Therapeutics 11/03/05 Array BioPharma Announces Drug Discovery Collaboration With Ono Pharmaceutical Co., Ltd. 10/31/05 Array BioPharma Reports Financial Results for the First Quarter of Fiscal 2006 10/24/05 Array BioPharma to Report Financial Results for the First Quarter Fiscal 2006 on October 31, 2005 10/13/05 Array BioPharma and Genentech Expand Strategic Oncology Collaboration 09/19/05 Array BioPharma to Present at the UBS Global Life Sciences Conference 08/31/05 Array BioPharma to Present at the Thomas Weisel Partners Healthcare Conference 2005 08/08/05 Array BioPharma's Anticancer Compound ARRY-334543 Cleared to Advance Into Human Clinical Trials 08/08/05 Array BioPharma Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2005 08/05/05 Array BioPharma Amends Facility Lease 08/04/05 Array BioPharma Announces Lease Restatement 08/03/05 Array BioPharma to Report Financial Results for the Fourth Quarter and Full Year of Fiscal 2005 on August 8, 2005 07/19/05 InterMune and Array BioPharma Expand Hepatitis C Drug Discovery Collaboration 05/18/05 Array BioPharma to Present at the Fourth Annual Needham Biotechnology Conference 05/12/05 Array BioPharma to Present Data From Anti-Cancer Program at the American Society of Clinical Oncology Annual Meeting 05/10/05 Array BioPharma Receives Milestone Payment From Amgen 05/09/05 Array BioPharma Reports Financial Results for the Third Quarter of Fiscal 2005 05/04/05 Array BioPharma to Present at the Banc of America Securities Health Care Conference 2005 05/02/05 Array BioPharma to Report Financial Results for the Third Quarter of Fiscal 2005 on May 9, 2005 04/18/05 Array BioPharma Presents Data on Two Cancer Programs at the 96th Annual Meeting of the American Association for Cancer Research 04/07/05 Array BioPharma and Genentech Expand Oncology Collaboration 02/15/05 Array BioPharma to Present at the BIO CEO & Investor Conference 2005 02/08/05 Reminder - Array BioPharma to Report Financial Results for the Second Quarter of Fiscal 2005 on February 7, 2005 02/07/05 Array BioPharma Reports Financial Results for the Second Quarter of Fiscal 2005 01/31/05 Array BioPharma to Report Financial Results for the Second Quarter of Fiscal 2005 on February 7, 2005 01/18/05 Array BioPharma to Present at the Piper Jaffray Health Care Conference 12/14/04 Array BioPharma Announces Exercise of Over-Allotment Option and Completion Of Common Stock Offering 12/09/04 Array BioPharma Announces Pricing of a Public Offering of 8,000,000 Shares of Common Stock 12/07/04 Array BioPharma Grants InterMune Expanded Rights Under Hepatitis C Discovery Agreement 11/30/04 Array BioPharma Announces Offering of Common Stock 11/01/04 Array Biopharma Reports Financial Results for the First Quarter of Fiscal 2005 11/01/04 Intermune Announces Presentation of Data on Potent HCV Protease Inhibitor Drug Candidates 10/27/04 Array BioPharma Reports Financial Results For The First Quarter Of Fiscal 2005 On November 1, 2004 10/21/04 Array Biopharma to Present at the Bio-Europe 2004 Partnering Conference 10/05/04 Array BioPharma Appoints Ronald B. Franklin, Ph.D., D.A.B.T Senior Director Drug Metabolism 10/04/04 Array BioPharma to Present at the BIO Emerging Company Investor Forum 09/14/04 Array CEO Robert E. Conway to Speak at the UBS Global Life Sciences Conference 08/25/04 Array CEO Robert E. Conway to Speak at the Thomas Weisel Partners Healthcare Tailwinds 2004 Conference 08/10/04 Array BioPharma and QLT Announce Drug Discovery Collaboration Focused on Cancer 08/02/04 Array BioPharma Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2004 07/27/04 Array BioPharma To Report Financial Results for the Fourth Quarter and Full Year of Fiscal 2004 on August 2, 2004 06/14/04 Array BioPharma Achieves Milestone for Initiation of Phase I Clinical Trial for Anticancer Compound ARRY-142886 06/09/04 Array CEO Robert E. Conway to Speak at the Third Annual Needham Biotechnology Conference 06/03/04 Trimeris and Array BioPharma Extend Antiviral Drug Discovery Agreement 06/02/04 Array CEO Robert E. Conway to Speak at the BIO 2004 Business Forum 06/01/04 Array BioPharma Receives Milestone Payment From Amgen 05/25/04 Array CEO Robert E. Conway to Speak at the Friedman Billings Ramsey 8th Annual Growth Investor Conference 05/06/04 Array CEO Robert E. Conway to Speak at the Banc of America Securities Health Care Conference 05/03/04 Array BioPharma Reports Financial Results for the Third Quarter of Fiscal 2004 04/29/04 Array BioPharma Appoints Douglas E. Williams, Ph.D., to Its Board of Directors 04/27/04 Array BioPharma To Report Financial Results for the Third Quarter of Fiscal 2004 on May 3, 2004 04/22/04 Array BioPharma Inc. Files Shelf Registration Statement 04/05/04 Array BioPharma Announces Drug Discovery Collaboration With Takeda Chemical Industries, Ltd. 04/01/04 Reminder - Array CEO Robert E. Conway to Speak at the Future Leaders in the Biotech Industry Conference 03/27/04 Investigational MEK Inhibitor, ARRY-142886 (AZD6244), Combats Cancer Growth 03/19/04 Array BioPharma President Kevin Koch to Present at American Association for Cancer Research Meeting 03/16/04 Array CEO Robert E. Conway to Speak at the Future Leaders in the Biotech Industry Conference 03/05/04 Array BioPharma's Anticancer Compound ARRY-142886 Cleared to Advance Into Human Clinical Trials 02/19/04 Array BioPharma Appoints Drs. S. Gail Eckhardt And Randall K. Johnson to Its Scientific Advisory Board 02/10/04 Array CEO Robert E. Conway to Speak at BIO CEO & Investor Conference 02/02/04 Array BioPharma Reports Financial Results for the Second Quarter Of Fiscal 2004 01/27/04 Array BioPharma To Report Financial Results for the Second Quarter of Fiscal 2004 on February 2, 2004 01/05/04 Array BioPharma Announces Oncology Collaboration With Genentech 12/18/03 Array BioPharma and AstraZeneca Announce Oncology Collaboration 11/03/03 Array BioPharma Reports Financial Results for the First Quarter of Fiscal 2004 10/28/03 Array BioPharma to Report Financial Results for the First Quarter of Fiscal 2004 on November 3, 2003 09/09/03 Array CEO Robert E. Conway to Speak at the UBS Warburg Global Life Sciences Conference 08/21/03 Array CEO Robert E. Conway to Speak at the Thomas Weisel Partners' Healthcare Tailwinds 2003 Conference 08/04/03 Array BioPharma Reports Financial Results for the Fourth Quarter And Full Year of Fiscal 2003 07/29/03 Array BioPharma to Report Financial Results for the Fourth Quarter and Full Year of Fiscal 2003 On August 4, 2003 07/07/03 GenPath and Array BioPharma Announce Drug Discovery Collaboration Focused on Cancer 06/17/03 Updated Speaking Time - Array CEO Robert E. Conway to Speak at the BIO 2003 Annual Convention Business Forum 06/11/03 Array CEO Robert E. Conway to Speak at the BIO 2003 Annual Convention Business Forum 05/22/03 Array CEO Robert E. Conway to Speak at Needham & Company Biotechnology Conference 05/05/03 Array BioPharma Reports Financial Results For the Third Quarter of Fiscal 2003 04/28/03 Array BioPharma Reports Financial Results for the Third Quarter of Fiscal 2003 on May 5, 2003 03/31/03 Array BioPharma Lowers Revenue Forecast 02/25/03 Array CEO Robert E. Conway To Speak at Lehman Brothers Healthcare Conference 02/11/03 Array CEO Robert E. Conway to Speak at BIO CEO & Investor Conference 02/03/03 Array BioPharma Reports Financial Results For The Second Quarter of Fiscal 2003 01/27/03 Array BioPharma To Report Financial Results for the Second Quarter of Fiscal 2003 On February 3, 2003 01/21/03 Array CEO Robert E. Conway to Speak at UBS Warburg Global Healthcare Services Conference 12/19/02 Array BioPharma Adjusts Growth Expectations for Fiscal 2003 11/04/02 Array BioPharma Reports Financial Results for the First Quarter of Fiscal 2003 10/31/02 Array BioPharma Appoints Gil Van Lunsen From KPMG to Its Board of Directors 10/28/02 Array BioPharma To Report Financial Results for the First Quarter of Fiscal 2003 On November 4, 2002 09/30/02 InterMune and Array BioPharma Announce Drug Discovery Collaboration Focused on Hepatitis 09/23/02 Array CEO Robert E. Conway to Speak At UBS Warburg Global Life Sciences Conference 08/05/02 Array BioPharma Reports Financial Results For The Fourth Quarter and Full Year of Fiscal 2002 07/30/02 Array BioPharma to Report Financial Results for the Fourth Quarter and Full Year of Fiscal 2002 On August 5, 2002 05/22/02 Array CEO Robert E. Conway to Speak At Needham & Company Biotechnology Conference 05/14/02 Array BioPharma Appoints James D. Winkler, Ph.D. Discovery Biology Director 05/13/02 Array BioPharma Added to Nasdaq Biotechnology Index 05/06/02 Array BioPharma Reports Financial Results for the Third Quarter of Fiscal 2002 05/01/02 Array BioPharma Appoints John R. Moore General Counsel 04/26/02 Array CEO Robert E. Conway to Speak at Deutsche Bank Securities Health Care Conference 04/25/02 Array BioPharma to Report Financial Results for the Third Quarter of Fiscal 2002 on May 6, 2002 04/22/02 Callisto, Array BioPharma In Collaboration 04/05/02 Aptus and Array BioPharma Announce Drug Discovery Collaboration; Small Molecule Drug Discovery Agreement Targets GPCRs 03/13/02 Array BioPharma Announces Drug Discovery Collaboration With Japan Tobacco 02/27/02 Array BioPharma Announces Exercise of Over-Allotment Option in Public Offering 02/19/02 Array BioPharma to Expand Laboratory Space 02/19/02 Array CEO Robert E. Conway to Speak At Bio CEO & Investor Conference and Lehman Brothers Healthcare Conference 02/14/02 Array BioPharma Schedules Conference Call to Provide Financial Guidance 02/13/02 Array BioPharma Announces Pricing of Stock Offering 01/22/02 Array BioPharma Reports Financial Results For The Second Quarter of Fiscal 2002 01/18/02 Array BioPharma to Report Financial Results For The Second Quarter of Fiscal 2002 on January 22, 2002 01/16/02 Array BioPharma Files Registration Statement For Public Offering of Common Stock 01/15/02 Array BioPharma Announces Compound Acquisition Agreements With Pfizer 01/14/02 Array BioPharma Initiates a New Drug Discovery Program With Amgen 11/15/01 Array CEO Robert E. Conway to Speak at Robertson Stephens Medical Conference On Thursday, November 29, 2001 11/05/01 Array BioPharma Reports Financial Results For the First Quarter of Fiscal 2002 10/29/01 Array BioPharma to Report Financial Results for the First Quarter Of Fiscal 2002 on November 5, 2001 10/02/01 Array CEO Robert E. Conway to Speak at UBS Warburg Global Life Sciences Conference on Monday, October 8, 2001 09/20/01 Array BioPharma Announces Drug Discovery Deal With Takeda Chemical Industries, Ltd 09/05/01 Array BioPharma and Vertex Pharmaceuticals Establish Drug Discovery Agreement; Collaboration to Focus on Discovering Novel Drugs Targeting Phosphatases 08/14/01 Array and ICOS Establish Drug Discovery Collaboration Exploiting A Novel Chemical Proteomics Platform 08/06/01 Array BioPharma Accelerates Drug Discovery With State-of-the-Art Electronic Information System 08/06/01 Array BioPharma Reports Financial Results for the Fourth Quarter And Full Year of Fiscal 2001 08/06/01 Trimeris And Array Biopharma Sign Antiviral Drug Discovery Agreement 08/03/01 Array BioPharma Inc. Board Adopts Stockholder Rights Plan 07/31/01 Array BioPharma to Report Financial Results for the Fourth Quarter And Full Year of Fiscal 2001 on August 6, 2001 05/07/01 Array BioPharma Reports Financial Results for the Third Quarter And the First Nine Months of Fiscal 2001 05/02/01 Array BioPharma Inc. to Report Third Quarter Earnings For Fiscal Year 2001 on May 7th, 2001 04/04/01 Array BioPharma to Triple Laboratory Space Over Next Four Years 02/05/01 Array BioPharma Reports Financial Results for the Second Quarter And the First Six Months of Fiscal 2001 02/01/01 Array BioPharma Inc. to Report Second Quarter Earnings for Fiscal Year 2001 On February 5th, 2001 01/04/01 Array BioPharma Appoints John L. Zabriskie Ph.D. to Its Board of Directors 12/07/00 Array BioPharma Announces Exercise of Over-Allotment Option In Initial Public Offering 11/17/00 Array BioPharma Announces Initial Public Offering 11/01/00 Array Announces Drug Discovery Collaboration with Amgen 10/03/00 Array Biopharma Announces Library Agreement with Immunex 09/15/00 Array BioPharma Inc. Announces Filing of Registration Statement 09/12/00 Array BioPharma Inc. and Merck & Co. Inc. Expand Their Existing Compound Development and Supply Agreement 08/03/00 Icos and Array BioPharma Expand Drug Discovery Collaboration 07/12/00 Array BioPharma Doubles Laboratory Space 05/10/00 Array BioPharma and Tularik Announce Library Synthesis Agreement 03/28/00 Array BioPharma Forms Chemistry-Based Research Agreement with Lilly for Drug Discovery 03/13/00 Array BioPharma Announces Library Agreement with Asahi Chemical Industry Co., Ltd 12/07/99 Array BioPharma, Inc. Raises $8 Million in Second Round Financing 11/30/99 Array BioPharma Names Robert E. Conway as Chief Executive Officer 10/12/99 Neurocrine and Array BioPharma Announce Drug Discovery Collaboration 08/04/99 Array BioPharma Announces Library Agreement with Tularik 05/28/99 Chiroscience and Array BioPharma Enter Compound Library Agreement 02/09/99 Icos and Array BioPharma announce Drug Discovery Collaboration